Research article summary (published 24 Aug 2009):

FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Kuehn, Bridget M (BM);

Journal and publication information

Publication Type: News

Journal: JAMA : the journal of the American Medical Association (JAMA), published in United States. (Language: eng)

Reference: 2009-Aug; vol 302 (issue 8) : pp 833-4

Dates: Created 2009/08/26; Completed 2009/08/31;

PMID: 19706851, status: MEDLINE (last retrieval date: 8/31/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Adolescent Antipsychotic Agents - adverse effects; therapeutic use Benzodiazepines - adverse effects; therapeutic use Bipolar Disorder - drug therapy Child Dibenzothiazepines - adverse effects; therapeutic use Drug Approval

Drug Approval Humans Piperazines - adverse effects; therapeutic use Schizophrenia - drug therapy Thiazoles - adverse effects; therapeutic use United States United States Food and Drug Administration

Associated Chemicals: Antipsychotic Agents (0) ; Dibenzothiazepines (0) ; Piperazines (0) ; Thiazoles (0) ; quetiapine (0) ; Benzodiazepines (12794-10-4) ; olanzapine (132539-06-1) ; ziprasidone (146939-27-7)

Related articles

These are the highest related articles currently in the database:

• Ziprasidone approved. 30 May 2001
• New schizophrenia drug. 29 Apr 2001
• Validity of conclusions about quetiapine. 13 Jan 2008
• DO comments on bipolar disorder supplement. 29 Nov 2004
• Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use. 30 Dec 2007
• Psychopharmacology update: why choose quetiapine for bipolar illness? 30 Mar 2007
• Measuring outcome in schizophrenia: differences among the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations. 30 Dec 1997
• Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials. 30 Jul 2005
• Antipsychotic choices now include quetiapine. 13 Nov 1997
• Introduction: a new era in the pharmacotherapy of psychotic disorders. 30 Dec 2000

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.